16.07.2021 • News

New Mountain Acquires Ascensus Specialties

Private equity group New Mountain Capital has acquired Ascensus Specialties, a provider of specialty materials headquartered in Bellevue, Washington, USA. Financial details were not disclosed. The former majority shareholder Wind Point Partners will reinvest in Ascensus in partnership with New Mountain. Wind Point acquired Ascensus in January 2015 from Dow Chemical.

According to New Mountain, Ascensus is the world leader in borohydride, borane and specialty alcoholates chemistries, and also supplies a diversified range of reagents and catalysts to customers worldwide in the pharmaceutical, microelectronics, and other specialty end markets. Ascensus operates three facilities in Elma, Washington; Evans City, Pennsylvania; and Newburyport, Massachusetts.

“Wind Point continues to be a great partner, and New Mountain brings proven success in life sciences, with companies like Avantor, Gelest, Aceto and ILC Dover. With this new partnership, Ascensus will have tremendous access to capital and resources to further invest behind R&D and product innovation in a transformative way,” said the company’s CEO. Mike Huff.

In April, Ascensus completed its acquisition of Strem Chemicals, a US manufacturer of specialty chemicals, including high-purity, research-grade catalysts, ligands, organometallics, metal carbonyls and chemical vapor deposition (CVD)/atomic layer deposition (ALD) precursors for markets such as life sciences and microelectronics, among others.

Headquartered in Newburyport, Massachusetts, Strem also provides custom synthesis and CGMP manufacturing services for high-potency APIs.

Author: Elaine Burridge, Freelance Journalist

Private equity group New Mountain Capital has acquired Ascensus Specialties, a...
Private equity group New Mountain Capital has acquired Ascensus Specialties, a provider of specialty materials headquartered in Bellevue, Washington, USA. The former majority shareholder Wind Point Partners will reinvest in Ascensus in partnership with New Mountain. (c) Cytonn Photography

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Digital Validation
Transforming from Paper to Digital

Digital Validation

Our experts will delve into the recently released International Society for Pharmaceutical Engineering (ISPE) Good Practice Guide: Digital Validation